Evidence map›Paper›PMID 40137729›Full record

ArticlePathogens (Basel, Switzerland)2025

Meryem Boujnane, Mohamed Zommiti, Olivier Lesouhaitier, Mounir Ferchichi, Ali Tahrioui, Amine M Boukerb, Nathalie Connil

Abstract read
In one paragraph

Article in Pathogens (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. The therapeutic potential ofFrontiers in microbiology · 2026
    Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Meryem BoujnaneCBSA UR 4312, Université de Rouen Normandie, Université de Caen Normandie, Normandie Université, F-76000 Rouen, France.
Mohamed ZommitiCBSA UR 4312, Université de Rouen Normandie, Université de Caen Normandie, Normandie Université, F-76000 Rouen, France.ORCID 0000-0003-1964-1724
Olivier LesouhaitierCBSA UR 4312, Université de Rouen Normandie, Université de Caen Normandie, Normandie Université, F-76000 Rouen, France.ORCID 0000-0001-8235-8919
Mounir FerchichiUnité de Protéomique Fonctionnelle et Potentiel Nutraceutique de la Biodiversité de Tunisie, Institut Supérieur des Sciences Biologiques Appliquées de Tunis, Université Tunis El-Manar, Tunis 1006, Tunisia.
Ali TahriouiCBSA UR 4312, Université de Rouen Normandie, Université de Caen Normandie, Normandie Université, F-76000 Rouen, France.ORCID 0000-0003-4064-820X
Amine M BoukerbCBSA UR 4312, Université de Rouen Normandie, Université de Caen Normandie, Normandie Université, F-76000 Rouen, France.ORCID 0000-0002-8349-6739
Nathalie ConnilCBSA UR 4312, Université de Rouen Normandie, Université de Caen Normandie, Normandie Université, F-76000 Rouen, France.ORCID 0000-0002-7969-0950

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Caenorhabditis elegansPediococcus pentosaceusProbioticsPseudomonas aeruginosaPseudomonas InfectionsAnimalsCaco-2 CellsHumansLongevityQuorum SensingVirulenceanti-virulenceCaenorhabditis elegansPediococcus pentosaceusprobioticPseudomonas aeruginosaquorum sensing

Identifiers

PMID40137729
PMCPMC11945076

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.